← Leaderboards
Alan D Marmorstein
Cleveland Clinic Foundation
$7,661,857
Attributed
$7,661,857
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $954.6K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$7,661,857 · 5
By mechanism
R01$6,434,690 · 2
R03$451,958 · 1
U01$397,500 · 1
R56$377,709 · 1
Top collaborators
No co-investigators on record.
Most similar at Cleveland Clinic Foundation
Same institution · by research overlap
- Bela Anand-Apte$12,006,070
- Lihua Y Marmorstein$4,133,800
- Kang Zhang$12,829,337
- Stanley L Hazen$59,550,078
- Joe Gilbert Hollyfield$7,576,094
Others in their field
Top investigators on “Macular Degeneration”
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Rohit Varma · University Of Southern California$50,124,787
- Maureen G Maguire · University Of Pennsylvania$38,506,792
- Martin Friedlander · Scripps Research Institute$35,843,206
- Cecilia Sungmin Lee · University Of Washington$32,086,169
- Krzysztof Palczewski · University Of California-Irvine$27,513,979
Research focus
Macular DegenerationBlindnessElectroretinographyCellsAffectProteinsExhibitsMouse ModelGenesGene ExpressionKnock-OutPreventVisionHuman TissueRetinal Pigment EpitheliumAnionsGoblet CellsHistopathologyTreatment StrategyBicarbonatesPhysiologyFunctional DisorderColonLight
Grant awards (23)
Preclinical testing of iPSC derived retinal pigment epithelium to treat macular degeneration$397,500
U01 · FY2019 · EY · contact PI
Bicarbonate Regulation of Aqueous Flow$350,595
R01 · FY2015 · EY · contact PI
Bicarbonate Regulation of Aqueous Flow$350,595
R01 · FY2014 · EY · contact PI
Bestrophin and retinal disease$440,713
R01 · FY2013 · EY · contact PI
Bicarbonate Regulation of Aqueous Flow$306,851
R01 · FY2013 · EY · contact PI
Bestrophin and retinal disease$76,258
R01 · FY2013 · EY · contact PI
Bicarbonate Regulation of Aqueous Flow$52,961
R01 · FY2013 · EY · contact PI
Bestrophin and retinal disease$575,844
R01 · FY2012 · EY · contact PI
Bicarbonate Regulation of Aqueous Flow$378,750
R01 · FY2012 · EY · contact PI
Bestrophin and retinal disease$572,056
R01 · FY2011 · EY · contact PI
Bestrophin and Retinal Disease$377,709
R56 · FY2009 · EY · contact PI
Bestrophin and Retinal Disease$359,234
R01 · FY2008 · EY · contact PI
Bestrophin and Retinal Disease$366,565
R01 · FY2007 · EY · contact PI
Bestrophin and Retinal Disease$368,629
R01 · FY2006 · EY · contact PI
Bestrophin and Retinal Disease$376,458
R01 · FY2005 · EY
A New Method for Retinal Imaging$150,500
R03 · FY2005 · EY
Bestrophin and Retinal Disease$376,250
R01 · FY2004 · EY
A New Method for Retinal Imaging$150,500
R03 · FY2004 · EY
BESTROPHIN AND RETINAL DISEASE$377,291
R01 · FY2003 · EY
New Method for Retinal Imaging$150,958
R03 · FY2003 · EY
BESTROPHIN AND RETINAL DISEASE$401,640
R01 · FY2002 · EY
BESTROPHIN AND RETINAL DISEASE$358,000
R01 · FY2001 · EY
BESTROPHIN AND RETINAL DISEASE$346,000
R01 · FY2000 · EY